Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:16 PM
Ignite Modification Date:
2026-03-26 @ 3:16 PM
NCT ID:
NCT07433257
Eligibility Criteria:
Inclusion Criteria
* Carpal Tunnel Syndrome with Type 2 Diabetes Mellitus Group (Group 1):
* Age between 18 and 75 years
* Presence of clinical symptoms compatible with carpal tunnel syndrome (e.g., pain, paresthesia, numbness) for at least 3 months
* Patients diagnosed with mild-to-moderate carpal tunnel syndrome based on electrophysiological findings
* Diagnosis of type 2 diabetes mellitus
* Regulated blood glucose levels, defined as hemoglobin A1c (HbA1c) \< 7%
* Idiopathic Carpal Tunnel Syndrome Group (Group 2):
* Age between 18 and 75 years
* Presence of clinical symptoms consistent with carpal tunnel syndrome (e.g., pain, paresthesia, numbness) for at least 3 months
* Patients diagnosed with mild-to-moderate carpal tunnel syndrome based on electrophysiological findings
* No diagnosis of diabetes mellitus
Exclusion Criteria
* Severe carpal tunnel syndrome based on electrophysiological findings
* Presence of polyneuropathy, cervical radiculopathy, brachial plexopathy, or thoracic outlet syndrome
* Uncontrolled blood glucose levels in the diabetic group (hemoglobin A1c ≥ 7%)
* Presence of another systemic disease, other than diabetes mellitus, that may cause carpal tunnel syndrome
* Presence of a rheumatological disease
* History of wrist surgery
* Less than 6 months since a local corticosteroid injection for carpal tunnel syndrome
* Less than 3 months since completion of a physical therapy program for carpal tunnel syndrome
* Infection at the intended injection site
* Presence of malignancy
* Pregnancy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT07433257
Study Brief:
Protocol Section:
NCT07433257